Cargando…

LIGAND-RECEPTOR INTERACTIONS AND DRUG DESIGN

Detalles Bibliográficos
Autores principales:	Zhang, Yanling, Song, Jianrui, Zhang, Xiaojun, Xiao, Yuanyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687977/ https://www.ncbi.nlm.nih.gov/pubmed/26715850 http://dx.doi.org/10.4137/BCI.S37978

Ejemplares similares

Sliding tethered ligands add topological interactions to the toolbox of ligand–receptor design
por: Bauer, Martin, et al.
Publicado: (2015)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

Rational drug design of CB2 receptor ligands: from 2012 to 2021
por: Wu, Yan-ran, et al.
Publicado: (2022)

In‐silico analysis of the strigolactone ligand‐receptor system
por: Bürger, Marco, et al.
Publicado: (2020)

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands
por: Günther, Robert, et al.
Publicado: (2012)

Opioids and oral P2Y12 receptor inhibitors: A drug–drug interaction
por: Kubica, Jacek
Publicado: (2022)

Designer drugs
por: Pesce, Amadeo J, et al.
Publicado: (2023)

Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer
por: Benelli, Roberto, et al.
Publicado: (2023)

Helicase and Its Interacting Factors: Regulation Mechanism, Characterization, Structure, and Application for Drug Design
por: Huang, Cheng-Yang, et al.
Publicado: (2015)

The Quantum Nature of Drug-Receptor Interactions: Deuteration Changes Binding Affinities for Histamine Receptor Ligands
por: Kržan, Mojca, et al.
Publicado: (2016)

Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Wang, Jinquan, et al.
Publicado: (2017)

Exploiting Ligand-Protein Conjugates to Monitor Ligand-Receptor Interactions
por: Haruki, Hirohito, et al.
Publicado: (2012)

Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
por: Singh, Vijay K, et al.
Publicado: (2015)

Development of a membrane-anchored ligand and receptor yeast two-hybrid system for ligand-receptor interaction identification
por: Li, Jingjing, et al.
Publicado: (2016)

Designer drugs and sexual dysfunction
por: Benyó, Mátyás
Publicado: (2015)

Anti-Cancer Drug Design
por: Moore, Michael
Publicado: (1985)

Molecular Modeling in Drug Design
por: Wade, Rebecca C., et al.
Publicado: (2019)

Computer-aided drug design
por: Ece, Abdulilah
Publicado: (2023)

Role of Computer-Aided Drug Design in Drug Development
por: Gu, Ruoxu, et al.
Publicado: (2023)

Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery
por: Mizera, Mikołaj, et al.
Publicado: (2021)

Trastuzumab-Peptide Interactions: Mechanism and Application in Structure-Based Ligand Design
por: Sun, Tian-Yang, et al.
Publicado: (2013)

Evolutionary design of selective adenosine receptor ligands
por: van der Eelke, Horst, et al.
Publicado: (2010)

Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing
por: Patil, Rohan, et al.
Publicado: (2010)

WONKA and OOMMPPAA: analysis of protein–ligand interaction data to direct structure-based drug design
por: Deane, Charlotte M., et al.
Publicado: (2017)

Plethora of Non-Covalent Interactions in Coordination and Organometallic Chemistry Are Modern Smart Tool for Materials Science, Catalysis, and Drugs Design
por: Novikov, Alexander S.
Publicado: (2022)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Drug Design and Discovery: Principles and Applications
por: Zhou, Shu-Feng, et al.
Publicado: (2017)

Drug Design—Past, Present, Future
por: Doytchinova, Irini
Publicado: (2022)

In Silico Drug Design and Discovery: Big Data for Small Molecule Design
por: Cerchia, Carmen, et al.
Publicado: (2022)

G protein-coupled receptors: computer-aided ligand discovery and computational structural analyses in the 2010s
por: Costanzi, Stefano
Publicado: (2013)

Cell responses without receptors and ligands, using nanosecond pulsed electric fields (nsPEFs)
por: Beebe, Stephen J
Publicado: (2013)

The flexibility–complementarity dichotomy in receptor–ligand interactions
por: Sun, Hongmei, et al.
Publicado: (2015)

Structural Analysis of Chemokine Receptor–Ligand Interactions
por: Arimont, Marta, et al.
Publicado: (2017)

Two-dimensional measurements of receptor-ligand interactions
por: Zheng, Songjie, et al.
Publicado: (2023)

Diversity in Notch ligand-receptor signaling interactions
por: Kuintzle, Rachael, et al.
Publicado: (2023)

Applications and analytical tools of cell communication based on ligand-receptor interactions at single cell level
por: Ma, Fen, et al.
Publicado: (2021)

Prediction of Ligand Binding Using an Approach Designed to Accommodate Diversity in Protein-Ligand Interactions
por: Marsh, Lorraine
Publicado: (2011)

Cobicistat: A case of mislabelled drug‐drug interaction risk?
por: Burger, David M., et al.
Publicado: (2020)

Drug-drug interactions with direct-acting antivirals — less is more
por: Wong, Grace Lai-Hung
Publicado: (2021)

Drug–drug Interactions: An Overlooked Dimension of the COVID-19 Pandemic
por: Beninger, Paul
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rb7mt2hgt1oq6fej53im52v81h